media release

Further Proposal from Akzo Nobel

Press Release: Akzo Nobel NV confirms that it has made a further indicative proposal to the Board of Imperial Chemical Industries PLC (“ICI”) under which Akzo Nobel would acquire ICI for 670p per share in cash.

Not for release, publication or distribution in, into or from Australia, Canada or Japan.

Arnhem, the Netherlands, August 6, 2007 - Akzo Nobel NV (“Akzo Nobel”) confirms that it has made a further indicative proposal to the Board of Imperial Chemical Industries PLC (“ICI”) under which Akzo Nobel would acquire ICI for 670p per share in cash.

In addition, ICI shareholders would receive a second interim dividend of up to 5p per share
pro rata by reference to where the completion date of the proposed offer falls between July 1, 2007 and December 31, 2007.

Nobel was able to make this increased proposal after further discussions with both ICI
Henkel KGaA (“Henkel”). As announced on 30 July 2007, Akzo Nobel has entered into an exclusive arrangement with Henkel for the sale, following completion of its proposed offer, of ICI’s Adhesives and Electronic Materials businesses. The consideration payable under this arrangement is £2.7 billion (calculated on a cash and debt free basis) Akzo Nobel and Henkel have negotiated a back to back agreement relating to this proposed sale which, subject to the approval of Henkel’s Shareholders’ Committee, they would intend to execute immediately prior to the formal announcement of an offer by Akzo Nobel for ICI.

exclusivity agreement with Henkel enables both Akzo Nobel and Henkel to each focus on the businesses that offer them most synergies thereby meeting their respective stated strategic and financial objectives. It would also allow Akzo Nobel to return further cash to its shareholders.
Board of ICI has agreed that Akzo Nobel can undertake certain limited due diligence. There can be no certainty that Akzo Nobel’s further indicative proposal will result in any offer or transaction. A further announcement will be made when appropriate.

Contact for this publication

Media Relations

For media requests only
Contact for other questions